Influence of time interval between surgery and radiotherapy on tumor regrowth

Journal of Experimental and Clinical Cancer Research

Volumn 24, Issue 1, 2005, Pages 109-116

  Cividalli, A ^a   Creton, G ^b   Ceciarelli, F ^a   Strigari, L ^c   Danesi, Donatella Tirindelli ^a   Benassi, M ^c  

^a ENEA C R CASACCIA   (Italy)

^b Villa Flaminia Hospital   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

IORT; Murine tumor; Radiotherapy; Subclinical disease; Time interval

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOOT; LEG; MOUSE; NONHUMAN; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; TUMOR GROWTH; TUMOR LOCALIZATION;

ANIMALS; CELL PROLIFERATION; FEMALE; MICE; NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 18544362762     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. MacComb W.S., Fletcher G.H.: Planned combination of surgery and radiation in the treatment of advanced different solid tumors. Am. J. Roentgenol. 77:397-415, 1957.
2. Suit H.: Assessment of the impact of local control on clinical outcome. In: Meyer J.L., Purdy J.A., (eds.) 3-D Conformal Radiotherapy, pp. 17-23. Karger, 1996.
3. Huang D.T., Johnson C.R., Schmidt-Ullrich R., Grimes M.: Postoperative radiotherapy in head and neck carcinoma with extracapsular lymphnode exstension and/or positive resection margins: a comparative study. Int. J. Radiat. Oncol. Biol. Phys. 23:737-742, 1992.
4. Tubiana M.: Repopulation in human tumours. Acta Oncol. 27:83-88, 1988.
5. Trott K.R., Kummermehr J.: What is known about tumour proliferation rates to choose between accelerated fractionation and hyperfractionation. Radiother. Oncol. 3:1-9, 1985.
6. Ang K.K., Trotti A., Brown B.W., Garden A.S., Foote R.L., Morrison W.H., et al.: Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 51:571-578, 2001.
7. Trott K.R., Kummermehr J.: Rapid repopulation in radiotherapy: a debate on mechanism. Accelerated repopulation in tumors and normal tissues. Radiother. Oncol. 22:159-160, 1991.
8. Parson J.T., Bova F.J., Million R.R.: A reevaluation of a split course technique for squamous cell carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 6:1645-1652, 1980.
9. Overgaard J., Hjelm-Hansen M., Johansen L.V., Andersen A.P.: Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol. 27:147-152, 1988.
10. Barton M.B., Keane T.J., Gadalla T., Maki E.: The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother. Oncol. 23:137-143, 1992.
11. Withers H.R., Peters L.J., Taylor J.M., Owen J.B., Morrison W.H., Schultheiss T.E., et al.: Local control of carcinoma of tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int. J. Radiat. Oncol. Biol. Phys. 33:549-562, 1995.
12. Taylor J.M., Withers H.R., Mendenhall W.M.: Dose-time considerations of head and neck squamous cell carcinomas treated with irradiation. Radiother. Oncol. 17:95-102, 1990.
13. Ang K.K.: Altered fractionation trials in head and neck cancer. Semin. Radiat. Oncol. 8:230-236, 1998.
14. Peters L.J., Ang K.K., Thames H.D.: Altered fractionation schedules. In: Perez C.A., Brady L.W., (eds). Principles and practice of radiation oncology, 2nd ed., pp. 97-113, Philadelphia, PA: J.B. Lippincott, 1992.
15. Peters L.J.: The efficacy of postoperative radiotherapy for advanced head and neck cancer: quality of evidence. Int. J. Radiat. Oncol. Biol. Phys. 40:527-528, 1998.
16. Peters L.J. and Withers H.R.: Applying radiobiological principles to combined modality treatment for head and neck cancer. The time factor. Int. J. Radiat. Oncol. Biol. Phys. 39:831-836, 1997.
17. Retski M., Demicheli R., and Hrushesky W.: Breast cancer screening: controversies and future directions. Curr. Opin. Obstet. Gynecol. 15:1-8, 2003.
18. Ben-Eliyahu S., Page G.G., Yirmiya R., and Shakhar G.: Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 80:880-888, 1999.
19. Hofer S.O., Molema G., Hermens R.A., Wanebo H.J., Reichner J.S., Hoekstra H.J.: The effect of surgical wounding on tumour development. Eur. J. Surg. Oncol. 25:231-243, 1999.
20. Mauro F., Cividalli A., Adami M.: Relative effectiveness of X-ray multifraction schedules: experiments on a murine tumor system in vivo. In: Broerse J.J.; Barendsen G.W.; Kal H.B.; Van der Kogel A.J., (eds) Proceedings of the 4th International Congress of Radiation Research (ICRR), (Abstr.) D1, 22, Amsterdam, 1983.
21. Eisen M.M.: Mathematical models in cell biology and cancer chemotherapy. New York, NY: Springer-Verlag, 1979.
22. Benassi M., Bianciardi L., Di Nallo A.: Radiation dose and effect probability distributions in radiotherapy. Phys. Med. 8:293-103, 1992.
23. Trefil J.S., Scaffher J.G., Looney W.B.: Method of extracting information on tumor response to single and combined modality treatment from growth curves. In: Busch H, (ed). Methods in cancer research, pp. 325-365. New York (NY): Academic Press, 1967.
24. Kellerer A.M., Rossi H.H.: The theory of dual radiation action. Curr. Topics Radiat. Res. 8:85-158, 1972.
25. Chadwick K.H., Leennhouts H.P.: A molecular theory of cell survival. Phys. Med. Biol. 18:78-87, 1973.
26. Wolbarst A.B.: Optimization of radiation therapy II: The critical voxel model. Int. J. Radiat. Oncol. Biol. Phys. 10:741-745, 1984.
27. Cividalli A., Arcangeli G., Cruciani G., Livdi E., Cordelli E., Danesi D.T.: Enhancement of radiation response by paclitaxel in mice according to different treatment schedules. Int. J. Radiat. Oncol. Biol. Phys. 40:1163-1170, 1998.
28. Marino C., Cividalli A.: Combined radiation and hyperthermia: effects of the number of heat fractions and their interval on normal and tumour tissues. Int. J. Hyperthermia 6:771-781, 1992.
29. Byers R.M., Clayman G.L., Guillamondequi O.M., Peters L.J., Goepfert H.: Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aereodigestive tract. Head Neck 14:133-138, 1992.
30. Vikram B., Strong E.W., Shah J.P., Spiro R.: Failure in the neck following multimodality treatment for head and neck cancer. Head Neck Surg. 6:724-727, 1984.
31. Waaijer A., Terhaard C.H., Dehnad H., Hordijk G.J., van Leeuwen M.S., Raaymakers C.P., et al.: Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother. Oncol. 66:271-276, 2003.
32. Nixon A.J., Recht A., Neuberg D., Connolly J.L., Schnitt S., Abner A., Harris J.R.: The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast conserving surgery and radiation therapy without systemic therapy. Int. J. Oncol. Biol. Phys. 30:17-21, 1994.
33. Barton M.B., Morgan G., Smee R., Tiver K.W., Hamilton C., Gebski V.: Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother. Oncol. 44:137-141, 1997.
34. Lee A.W., Chan D.K.: T1 nasopharingeal carcinoma: The effect of waiting time on tumour control. Int. J. Radiat. Oncol. Biol. Phys. 30:1111-1117, 1994.
35. Vikram B., Strong E.W., Shah J., Spiro R.H.: Elective postoperative radiation therapy in stages III and IV epidermoid carcinoma of the head and neck. Am. J. Surg. 140:580-584, 1980.
36. Trotti A., Klotch D.: Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of head and neck: Long-term results of a prospective trial. Head Neck 20:119-130, 1998.
37. Fortin A., Bairati I., Albert M., Moore L., Allard J., Couture C.: Effect of treatment delay on outcome on patients with early stage head and neck carcinoma receiving radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 52:929-936, 2002.
38. O'Sullivan B., Mackillop W., Grice B.: The influence of delay in the initiation of definitive radiotherapy in carcinoma of the tonsillar region. (abstract). Int. J. Radiat. Oncol. Biol. Phys. 42 (suppl):323, 1998.
39. Buchholz T.A., Austin-Seymour M.M., Moe R.E., Ellis G.K., Livingston R.B., Pelton J.G., et al.: Effect of delay in radiation in the combined modality treatment of breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 26:23-35, 1993.
40. Recht A., Come S.E., Gelman R.S., Goldstein M., Tishler S., Gore S.M., et al.: Integration of conservative surgery, radiotherapy and chemotherapy for the treatment of early stage, node positive breast cancer: Sequencing, timing, and outcome. J. Clin. Oncol. 9:1662-1667, 1991.
41. Recht A., Come S.E., Henderson I.C., Gelman R.S., Silver B., Hayes D.F., et al.: The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N. Engl. J. Med. 334:1356-1361, 1996.
42. Do V., Gebski V., Barton M.B.: The effect of waiting for radiotherapy for grade III-IV gliomas. Radiother. Oncol. 57:131-136, 2000.
43. Schwartz D.L., Einck J., Hunt K., Bruckner J., Conrad E., Koh W.J., et al.: The effect of delayed postoperative irradiation on local control of soft tissue sarcomas of the extremity and torso. Int. J. Radiat. Oncol. Biol. Phys. 52:1352-1359, 2002.
44. Peters L.J., Goepfert, H., Ang K.K., Byers R.M., Maor M.H., Guillamondegui O., et al.: Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 26:3-11, 1993.
45. Withers H.R., Peters L.J.: Transmutability of dose and time. Commentary on the first report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 48:1-2, 2002.
46. Withers H.R., Suwinski R.: Radiation dose response for subclinical metastases. Semin. Radiat. Oncol. 8:224-228, 1998.
47. Okunieff P., Morgan D., Niemierko A., and Suit H.D.: Radiation dose-response in human tumors. Int. J. Radiat. Oncol. Biol. Phys. 32 (4):1227-1237, 1995.
48. Suwinski R. and Withers H.R.: Time factor and treatment strategies in subclinical disease. Int. J. Radiat. Biol. 79:495-502, 2003.
49. Begg A.C., Steel G.G.: Cell Proliferation and growth rate of tumours. In: Steel G.G., (ed.) Basic Clinical Radiobiology. pp. 8-22. London: Arnold, 2002.
50. Huang J., Barbera L., Brouwers M., Browman G., Mackillop W.J.: Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J. Clin. Oncol. 21:555-563, 2003.
51. Kirkpatrick J.P., and Marks L.B.: Modeling killing and repopulation kinetics of subclinical cancer: direct calculations from clinical data. Int. J. Radiat. Oncol. Biol. Phys. 58:641-654, 2004.